A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Clinical trial NCT05967182 · RECRUITING
Trial details
- NCT number
- NCT05967182
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-16
- Primary completion
- 2027-07-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.